Insights

Innovative Heart Therapies BioVentrix specializes in minimally invasive solutions for heart failure treatment, specifically targeting dilated left ventricles. This focus presents opportunities to collaborate with cardiothoracic surgeons and heart centers seeking advanced, less invasive treatment options for their patients.

Strong Funding & Recent Leadership With recent $48.5 million Series A funding and new leadership appointments including a President and Co-CEO, BioVentrix is positioned for growth and expansion. These developments suggest a strategic push into broader markets and increased demand for their therapies.

Growing Market Presence The company's recent acquisitions and significant investments highlight a focus on expanding its product portfolio and market reach in the congestive heart failure space, creating potential sales opportunities with hospitals and specialty clinics looking for innovative treatment modalities.

Key Stakeholder Benefits BioVentrix’s technology offers clear benefits to patients, providers, and payors by reducing hospitalizations and invasive procedures. This positions sales teams to target multiple stakeholders across healthcare organizations emphasizing value-based care and cost reductions.

Technology Stack & Digital Engagement Utilizing advanced digital tools like Google Ads, Clicky, and modern web technologies shows BioVentrix’s active online presence and engagement strategies. There is potential to leverage digital channels for targeted outreach and strategic partnerships in the medical device and healthcare sectors.

Similar companies to BioVentrix

BioVentrix Tech Stack

BioVentrix uses 8 technology products and services including Clicky, Google Ads Conversion Tracking, MySQL, and more. Explore BioVentrix's tech stack below.

  • Clicky
    Analytics
  • Google Ads Conversion Tracking
    Analytics
  • MySQL
    Database
  • Modernizr
    Javascript Libraries
  • Google Tag Manager
    Tag Management
  • Ruby on Rails
    Web Frameworks
  • Helix Ultimate
    Web Frameworks
  • WPML
    Web Platform Extensions

Media & News

BioVentrix's Email Address Formats

BioVentrix uses at least 1 format(s):
BioVentrix Email FormatsExamplePercentage
FLast@bioventrix.comJDoe@bioventrix.com
89%
Last@bioventrix.comDoe@bioventrix.com
7%
LFirst@bioventrix.comDJohn@bioventrix.com
3%
FL@bioventrix.comJD@bioventrix.com
1%

Frequently Asked Questions

Where is BioVentrix's headquarters located?

Minus sign iconPlus sign icon
BioVentrix's main headquarters is located at 120 Forbes Blvd Mansfield, Massachusetts 02048 US. The company has employees across 2 continents, including North AmericaEurope.

What is BioVentrix's phone number?

Minus sign iconPlus sign icon
You can contact BioVentrix's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is BioVentrix's official website and social media links?

Minus sign iconPlus sign icon
BioVentrix's official website is bioventrix.com and has social profiles on LinkedIn.

What is BioVentrix's SIC code?

Minus sign iconPlus sign icon
BioVentrix's SIC code is 8731 - Commercial Physical and Biological Research.

How many employees does BioVentrix have currently?

Minus sign iconPlus sign icon
As of August 2025, BioVentrix has approximately 22 employees across 2 continents, including North AmericaEurope. Key team members include Vice President Of Therapy Development: L. B.President And Co-Ceo: S. C.President And Chief Executive Officer: K. M.. Explore BioVentrix's employee directory with LeadIQ.

What industry does BioVentrix belong to?

Minus sign iconPlus sign icon
BioVentrix operates in the Medical Equipment Manufacturing industry.

What technology does BioVentrix use?

Minus sign iconPlus sign icon
BioVentrix's tech stack includes ClickyGoogle Ads Conversion TrackingMySQLModernizrGoogle Tag ManagerRuby on RailsHelix UltimateWPML.

What is BioVentrix's email format?

Minus sign iconPlus sign icon
BioVentrix's email format typically follows the pattern of FLast@bioventrix.com. Find more BioVentrix email formats with LeadIQ.

How much funding has BioVentrix raised to date?

Minus sign iconPlus sign icon
As of August 2025, BioVentrix has raised $36M in funding. The last funding round occurred on Mar 30, 2019 for $22M.
BioVentrix

BioVentrix

Medical Equipment ManufacturingMassachusetts, United States11-50 Employees

BioVentrix, Inc. a specialty medical device company serving cardiothoracic surgeons and their patients with lifesaving heart failure therapies. BioVentrix technologies aim to improve cardiac function by directly addressing LV dilation.

The BioVentrix Revivent System is designed to support a minimally invasive procedure to treat a dilated left ventricle of patients with ischemic heart failure with reduced ejection fraction (HFrEF) and extensive left ventricular scar, who have a suboptimal response to guideline-directed medical therapy. The procedure uses myocardial micro-anchor implants to reconstruct the dilated left ventricle to produce a more efficient chamber.
BioVentrix offers benefits to all stakeholders in heart failure:

Patient – improved survival and QOL by treating the underlying cause of HF less invasively
Payor – reduced hospitalizations and avoidance of more expensive, highly invasive procedures like transplant and LVAD
Provider – become a pioneer in heart failure and offer unique solutions to your patients, in the growing and most expensive disease state in the world

Section iconCompany Overview

Headquarters
120 Forbes Blvd Mansfield, Massachusetts 02048 US
Phone number
SIC Code
8731 - Commercial Physical and Biological Research
Employees
11-50

Section iconFunding & Financials

  • $36M

    BioVentrix has raised a total of $36M of funding over 2 rounds. Their latest funding round was raised on Mar 30, 2019 in the amount of $22Mas a round of equity financing.

  • $1M$10M

    BioVentrix's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $36M

    BioVentrix has raised a total of $36M of funding over 2 rounds. Their latest funding round was raised on Mar 30, 2019 in the amount of $22Mas a round of equity financing.

  • $1M$10M

    BioVentrix's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.